In Brief: Ketoprofen Rx-to-OTC switch
Executive Summary
Ketoprofen Rx-to-OTC switch: Bayer and Whitehall-Robins Rx-to-OTC switch applications for the nonsteroidal anti-inflammatory drug for relief of pain and reduction of fever reaches "approvable" stage at FDA on July 19, three working days following unanimous FDA advisory committee recommendation for approval of the applications on July 14 ("The Pink Sheet" July 17, p. 9)...